The monitoring of gonadotrophin therapy by plasma oestradiol and progesterone determinations.
D000328:Adult; D001667:Binding, Competitive; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000627:therapeutic use; D004958:Estradiol / Q000097:blood*; D004970:Estrone / Q000652:urine; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D006062:Gonadotropins / Q000627:therapeutic use*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D007273:Injections, Intramuscular; D008596:Menotropins / Q000627:therapeutic use; D008598:Menstruation / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D010507:Periodicity; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine; D011374:Progesterone / Q000097:blood*; D011485:Protein Binding
D006063:Chorionic Gonadotropin; D006062:Gonadotropins; D004970:Estrone; D011374:Progesterone; D004958:Estradiol; D008596:Menotropins; D005640:Follicle Stimulating Hormone; D011276:Pregnanediol